Steve Grenon, BSEE Chief Operating Officer, LumagenicsIn c Steve is a serial entrepreneur, joining Lumagenics from Johnson and Johnson Surgical Vision where he served as head of R&D on the Dry Eye Business unit after the acquisition, in 2017, of his prior startup Company TearScience. Steve was the first employee ofTearScience and served as VP of R&D. He built a team of world class R&D professionals, developed an entire line of award winning product s, and commercialized those products worldwide. TearScience innovations has led to more than 100 patents making them the technology leader in the treatment and diagnostics of Meibomian Gland Disfunction (MGD).
Prior to TearScience, Steve served as the Chief Technology Officer of a Duke University startup, Volumetrics Medical Imaging, which was the first to innovate and patent ground breaking real -time 3D ultrasound technology . The company had a successful exit, licensing the technology to many large ultrasound companies . The prototype of the first 3D ultrasound is currently at the Smithsonian.
Steve began his medical device career at Hewlett Packard designing Bedside monitors and Cardiac Ultrasound equipment and was ultimately ranked in the top 1% of HP Engineer/Scientists . Steve has 34 issued medical device patents in the area treatments and Diagnostics, optics, acoustics, electronics, and software with more pending .
Steve received his BS in Electrical Engineering from Northeastern University and has taken advanced courses from Stanford and Boston University in statistics and Application Specific Integrated Circuit Design.
In his spare time , Steve serves on the board of directors at a local non-profit , and a small medical device company , he actively mentors young leaders, and enjoys fishing off the coast of North Carolina with his family .